Zunveyl Dosage
Generic name: benzgalantamine 5mg
Dosage form: tablet, delayed release
Medically reviewed by Drugs.com. Last updated on Aug 8, 2024.
Recommended Dosage and Administration
Dosage
The recommended starting dosage is 5 mg twice a day (10 mg/day) by mouth. Increase to initial maintenance dosage of 10 mg twice daily (20 mg/day) after a minimum of 4 weeks, based on clinical response and tolerability. Dosage may be increased to the maximum recommended dosage of 15 mg twice a day (30 mg/day) after a minimum of 4 weeks at 10 mg twice daily.
Administration
ZUNVEYL can be taken with or without food.
ZUNVEYL should not be taken with alcohol [see Clinical Pharmacology (12.3)].
Swallow whole; do not split, crush or chew.
Ensure adequate fluid intake during treatment.
Recommended Dosage in Patients with Hepatic Impairment
No dosage adjustment is recommended for patients with mild hepatic impairment (Child-Pugh score of 5-6). In patients with moderate hepatic impairment (Child-Pugh score of 7-9), the dosage should generally not exceed 10 mg twice daily (20 mg/day). The use of ZUNVEYL in patients with severe hepatic impairment (Child-Pugh score of 10-15) is not recommended [see Clinical Pharmacology (12.3)].
Recommended Dosage in Patients with Renal Impairment
In patients with creatinine clearance of 9 to 59 mL/min, the dosage should generally not exceed 10 mg twice daily (20 mg/day). In patients with creatinine clearance less than 9 mL/min, the use of ZUNVEYL is not recommended [see Clinical Pharmacology (12.3)].
More about Zunveyl (benzgalantamine)
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.